A miRNA expression signature in breast tumor tissue is associated with risk of distant metastasis

Thomas E. Rohan, Tao Wang, Sheila Weinmann, Yihong Wang, Juan Lin, Mindy S. Ginsberg, Olivier Loudig

Research output: Contribution to journalArticle

Abstract

Dysregulation of miRNA expression may influence breast cancer progression, and experimental evidence suggests that miRNA silencing might suppress breast cancer metastasis. However, the relationship between miRNA and metastasis must be confirmed before this approach can be applied in the clinic. To this end, we conducted a two-stage study in a cohort of 3,760 patients with breast cancer to first identify and then validate the association between miRNA expression and risk of distant metastasis. The first stage (discovery) entailed miRNA sequencing of 126 case-control pairs; qPCR was used to validate the findings in a separate set of 80 case-control pairs. The 13 miRNAs most differentially expressed between cases and controls were combined into an miRNA score that was significantly associated with risk of distant metastasis in a logistic regression model that also included clinical variables (tumor size and number of positive lymph nodes) (OR per unit increase in score = 1.30; 95% confidence interval, 1.03-1.66). The results of this study suggest that in women with invasive breast cancer, a miRNA score that incorporates both clinical variables and miRNA expression levels in breast tumor tissue is moderately predictive of risk of subsequent distant metastasis. Significance: A novel predictive scoring system for patients with breast cancer includes clinical variables and the expression levels of 13 miRNAs and may help to identify those at increased risk of distant metastasis.

Original languageEnglish (US)
Pages (from-to)1705-1713
Number of pages9
JournalCancer Research
Volume79
Issue number7
DOIs
StatePublished - Apr 1 2019

Fingerprint

MicroRNAs
Breast Neoplasms
Neoplasm Metastasis
Logistic Models
Lymph Nodes
Confidence Intervals

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A miRNA expression signature in breast tumor tissue is associated with risk of distant metastasis. / Rohan, Thomas E.; Wang, Tao; Weinmann, Sheila; Wang, Yihong; Lin, Juan; Ginsberg, Mindy S.; Loudig, Olivier.

In: Cancer Research, Vol. 79, No. 7, 01.04.2019, p. 1705-1713.

Research output: Contribution to journalArticle

@article{7a63bed41d974a199ccbc405f4f02dcb,
title = "A miRNA expression signature in breast tumor tissue is associated with risk of distant metastasis",
abstract = "Dysregulation of miRNA expression may influence breast cancer progression, and experimental evidence suggests that miRNA silencing might suppress breast cancer metastasis. However, the relationship between miRNA and metastasis must be confirmed before this approach can be applied in the clinic. To this end, we conducted a two-stage study in a cohort of 3,760 patients with breast cancer to first identify and then validate the association between miRNA expression and risk of distant metastasis. The first stage (discovery) entailed miRNA sequencing of 126 case-control pairs; qPCR was used to validate the findings in a separate set of 80 case-control pairs. The 13 miRNAs most differentially expressed between cases and controls were combined into an miRNA score that was significantly associated with risk of distant metastasis in a logistic regression model that also included clinical variables (tumor size and number of positive lymph nodes) (OR per unit increase in score = 1.30; 95{\%} confidence interval, 1.03-1.66). The results of this study suggest that in women with invasive breast cancer, a miRNA score that incorporates both clinical variables and miRNA expression levels in breast tumor tissue is moderately predictive of risk of subsequent distant metastasis. Significance: A novel predictive scoring system for patients with breast cancer includes clinical variables and the expression levels of 13 miRNAs and may help to identify those at increased risk of distant metastasis.",
author = "Rohan, {Thomas E.} and Tao Wang and Sheila Weinmann and Yihong Wang and Juan Lin and Ginsberg, {Mindy S.} and Olivier Loudig",
year = "2019",
month = "4",
day = "1",
doi = "10.1158/0008-5472.CAN-18-2779",
language = "English (US)",
volume = "79",
pages = "1705--1713",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - A miRNA expression signature in breast tumor tissue is associated with risk of distant metastasis

AU - Rohan, Thomas E.

AU - Wang, Tao

AU - Weinmann, Sheila

AU - Wang, Yihong

AU - Lin, Juan

AU - Ginsberg, Mindy S.

AU - Loudig, Olivier

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Dysregulation of miRNA expression may influence breast cancer progression, and experimental evidence suggests that miRNA silencing might suppress breast cancer metastasis. However, the relationship between miRNA and metastasis must be confirmed before this approach can be applied in the clinic. To this end, we conducted a two-stage study in a cohort of 3,760 patients with breast cancer to first identify and then validate the association between miRNA expression and risk of distant metastasis. The first stage (discovery) entailed miRNA sequencing of 126 case-control pairs; qPCR was used to validate the findings in a separate set of 80 case-control pairs. The 13 miRNAs most differentially expressed between cases and controls were combined into an miRNA score that was significantly associated with risk of distant metastasis in a logistic regression model that also included clinical variables (tumor size and number of positive lymph nodes) (OR per unit increase in score = 1.30; 95% confidence interval, 1.03-1.66). The results of this study suggest that in women with invasive breast cancer, a miRNA score that incorporates both clinical variables and miRNA expression levels in breast tumor tissue is moderately predictive of risk of subsequent distant metastasis. Significance: A novel predictive scoring system for patients with breast cancer includes clinical variables and the expression levels of 13 miRNAs and may help to identify those at increased risk of distant metastasis.

AB - Dysregulation of miRNA expression may influence breast cancer progression, and experimental evidence suggests that miRNA silencing might suppress breast cancer metastasis. However, the relationship between miRNA and metastasis must be confirmed before this approach can be applied in the clinic. To this end, we conducted a two-stage study in a cohort of 3,760 patients with breast cancer to first identify and then validate the association between miRNA expression and risk of distant metastasis. The first stage (discovery) entailed miRNA sequencing of 126 case-control pairs; qPCR was used to validate the findings in a separate set of 80 case-control pairs. The 13 miRNAs most differentially expressed between cases and controls were combined into an miRNA score that was significantly associated with risk of distant metastasis in a logistic regression model that also included clinical variables (tumor size and number of positive lymph nodes) (OR per unit increase in score = 1.30; 95% confidence interval, 1.03-1.66). The results of this study suggest that in women with invasive breast cancer, a miRNA score that incorporates both clinical variables and miRNA expression levels in breast tumor tissue is moderately predictive of risk of subsequent distant metastasis. Significance: A novel predictive scoring system for patients with breast cancer includes clinical variables and the expression levels of 13 miRNAs and may help to identify those at increased risk of distant metastasis.

UR - http://www.scopus.com/inward/record.url?scp=85064230495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064230495&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-18-2779

DO - 10.1158/0008-5472.CAN-18-2779

M3 - Article

VL - 79

SP - 1705

EP - 1713

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 7

ER -